Man Group plc - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 204 filers reported holding HERON THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 2.25 and the average weighting 0.5%.

Quarter-by-quarter ownership
Man Group plc ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$246,000
-94.7%
43,000
-86.4%
0.00%
-95.7%
Q2 2020$4,636,000
+20.8%
315,161
+93.0%
0.02%
+76.9%
Q4 2019$3,839,000
+610.9%
163,328
+462.5%
0.01%
+550.0%
Q2 2019$540,000
-49.8%
29,036
-34.1%
0.00%
-50.0%
Q1 2019$1,076,000
-31.8%
44,040
-27.5%
0.00%
-42.9%
Q4 2018$1,577,000
+120.3%
60,782
+229.8%
0.01%
+133.3%
Q2 2018$716,00018,4320.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders